Endothelial dysfunction, inflammation and diabetes.
Dandona
Paresh
P
Division of Endocrinology, Diabetes and Metabolism, State University of New York at Buffalo and Kaleida Health, 3 Gates Circle, Buffalo, NY 14209, USA. pdandona@Kaleidahealth.org
Aljada
Ahmad
A
Chaudhuri
Ajay
A
Mohanty
Priya
P
D020909:Acarbose / Q000276:immunology / Q000627:therapeutic use; D000818:Animals; D002317:Cardiovascular Agents / Q000276:immunology* / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000276:immunology*; D003925:Diabetic Angiopathies / Q000188:drug therapy / Q000276:immunology*; D004730:Endothelium, Vascular / Q000276:immunology*; D006801:Humans; D007004:Hypoglycemic Agents / Q000276:immunology* / Q000627:therapeutic use; D007249:Inflammation / Q000276:immunology*; D007333:Insulin Resistance / Q000276:immunology; D008687:Metformin / Q000276:immunology / Q000627:therapeutic use; D009765:Obesity / Q000276:immunology; D018384:Oxidative Stress / Q000276:immunology; D013453:Sulfonylurea Compounds / Q000276:immunology / Q000627:therapeutic use; D045162:Thiazolidinediones / Q000276:immunology / Q000627:therapeutic use
D002317:Cardiovascular Agents; D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds; D045162:Thiazolidinediones; D008687:Metformin; D020909:Acarbose